Effects of Fish Oil on Platelet Function and Coagulation
- Conditions
- Platelet Aggregation, SpontaneousAtherosclerosisSurgery
- Interventions
- Registration Number
- NCT03048981
- Lead Sponsor
- Region Skane
- Brief Summary
Many patients undergoing surgery use naturopathic drugs, including fish oil. Fish oil has been reported to increase bleeding in patients through inhibiting platelet aggregation and prolonging of clot formation time. The Swedish Medical Products Agency recommends that patients stop taking the naturopathic medicines including fish oil two weeks prior planed surgery. The aim of this study is to examine the effects of fish oil given to healthy volunteers using point of care coagulation assessment and flow dependent Cellix instrument before and after intake of fish oil.
- Detailed Description
Healthy volunteers will be given maximum dose of fish oil for 7 days. Blood samples will be collected before and immediately after the 7 days of intake and analysed using point of care coagulation assessment instruments and flow dependent platelet aggregation using a microfluid flow controlled system (Cellix). For point of care coagulation assessment the multiple electrode platelet aggregometer Multiplate, the viscoelastic rotational thromboelastometers ROTEM and Sonoclot will be used. Flow cytometry may also be utilized.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- Non smoking healthy volunteers with written consent to participate
- Medication affecting coagulation or platelets within 14 days priori to inclusion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Fish oil intake Fish oil Healthy volunteers given maximum dose of fish oil for 10 days.
- Primary Outcome Measures
Name Time Method Thrombocyte aggregation measured with Cellix's microfluidic pumps and biochips Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline Cellix's microfluidic pumps and biochips gives an thrombosis area proportional to thrombocyte aggregation
Thrombocyte aggregation measured with multiple electrode aggregometry Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline Multiple electrode aggregometry gives a area under the curve proportional to thrombocyte aggregation
- Secondary Outcome Measures
Name Time Method Coagulation measured with the viscohemostatic instrument and Sonoclot Change of coagulation directly after intake period of 7 days compared to baseline Viscohemostatic instrument
Coagulation measured with the viscohemostatic instrument ROTEM Change of coagulation directly after intake period of 7 days compared to baseline Viscohemostatic instrument
Trial Locations
- Locations (1)
Intensive and perioperative care. Skåne University Hospital. Lund
🇸🇪Lund, Skåne, Sweden